USG Programs

This tracker provides regularly updated information on U.S. government funding for global health. It includes historical trends and tracks funding levels throughout the appropriations process. Data can be customized by fiscal year, sector, and U.S. agency. 

This report finds the public is generally supportive of U.S. distribution of vaccines internationally, though more likely to prefer the U.S. playing a major role versus a leading one, and there are partisan differences. The analysis also examines how different information affects the public’s views.

This primer provides an overview of congressional engagement in global health. It examines the structure of Congress and its role and key activities in global health. It then illustrates these by examining two global health examples: the creation and evolution of PEPFAR and the 2014/2015 Ebola outbreak in West Africa.

This data note assesses where the U.S. government has existing global health assets that could be mobilized when and if needed to assist in the COVID-19 response in low and middle income countries.

This data note provides an accounting of publicly-available information on donor funding to date for the global coronavirus (COVID-19) response.

This data note provides an updated comprehensive summary of donor funding for the Ebola response in the DRC.

The first comprehensive summary of donor funding for the response to the Ebola outbreak in the Democratic Republic of Congo estimates that at least $546 million was provided by donors from August 2018, when the outbreak started, through September 2019.

This Vaccine Monitor survey shows the public is largely supportive of the U.S. role in distributing COVID-19 vaccines globally, as well as other response efforts including the distribution of masks and COVID-19 rapid tests.

This analysis provides an initial look at how PEPFAR is currently defining and approaching sustained epidemic control at the country level.

These figures provide a general overview of U.S. funding for global health.